Solid Biosciences (SLDB) Operating Margin (2022 - 2024)
Historic Operating Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 53194.67%.
- Solid Biosciences' Operating Margin changed N/A to 53194.67% in Q4 2024 from the same period last year, while for Dec 2024 it was 38155.29%, marking a year-over-year decrease of 480033800.0%. This contributed to the annual value of 38155.29% for FY2024, which is N/A changed from last year.
- As of Q4 2024, Solid Biosciences' Operating Margin stood at 53194.67%.
- Solid Biosciences' 5-year Operating Margin high stood at 53194.67% for Q4 2024, and its period low was 411.44% during Q2 2022.
- Moreover, its 3-year median value for Operating Margin was 29926.53% (2024), whereas its average is 30335.37%.
- Over the last 5 years, Solid Biosciences' Operating Margin had its largest YoY gain of 18047200bps in 2024, and its largest YoY loss of 18047200bps in 2024.
- Solid Biosciences' Operating Margin (Quarter) stood at 411.44% in 2022, then surged by 6534bps to 26471.07% in 2023, then soared by 101bps to 53194.67% in 2024.
- Its Operating Margin was 53194.67% in Q4 2024, compared to 42904.88% in Q3 2024 and 31577.27% in Q2 2024.